FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/056992 [Registered on: 28/08/2023] Trial Registered Prospectively
Last Modified On: 09/03/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Other 
Public Title of Study   Capability of sealing gel on bacterial microleakage at implant abutment junction - a randomized clinical control trial 
Scientific Title of Study   Effect of sealing gel on bacterial microleakage at implant abutment junction - a randomized control trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Deepak Vikhe  
Designation  Associate professor  
Affiliation  Rural dental college, Maharashtra, Loni 
Address  Pravara institute of medical sciences loni, district Ahmadnagar opd no 401 department of prosthodontics pg section

Ahmadnagar
MAHARASHTRA
413736
India 
Phone  9822811117  
Fax    
Email  drdeepak_mvikhe@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Umesh Palekar 
Designation  Head of department Prosthodontics 
Affiliation  Rural dental college, Maharashtra,Loni 
Address  Pravara institute of medical sciences loni, district Ahmadnagar opd no 401 department of prosthodontics pg section

Ahmadnagar
MAHARASHTRA
413736
India 
Phone  7000136334  
Fax    
Email  umeshpalekar@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Deepak Vikhe  
Designation  Associate professor  
Affiliation  Rural dental college, Maharashtra,Loni 
Address  Pravara institute of medical sciences loni, district Ahmadnagar opd no 401 department of prosthodontics pg section

Ahmadnagar
MAHARASHTRA
413736
India 
Phone  9822811117  
Fax    
Email  drdeepak_mvikhe@yahoo.com  
 
Source of Monetary or Material Support  
self finance by post graduate Pravara institute of medical sciences loni, district Ahmadnagar opd no 401 department of prosthodontics pg section 
 
Primary Sponsor  
Name  Pravara institute of medical sciences 
Address  Pravara institute of medical sciences loni, district Ahmadnagar 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr deepak vikhe  Pravara institute of medical sciences loni, district Ahmadnagar  OPD no 401 Rural dental college, Pravara institute of medical sciences
Ahmadnagar
MAHARASHTRA 
9822811117

drdeepak_mvikhe@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committee pims -du  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K069||Disorder of gingiva and edentulousalveolar ridge, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Sealing gel GROUP A Technovent medical grade silicone  Placing abutment after injecting sealing gel in internal compartment of implant and microbiological analysis after 15 days 
Comparator Agent  Without sealing gel - GROUP B  Placing abutment without sealing gel in internal compartment of implant and microbiological analysis after 15 days  
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1) Patients with already placed implant
2) Patient requiring/indicating implant supported prosthesis.
3) Patient consenting for study
 
 
ExclusionCriteria 
Details  1) Patient with poor oral hygiene.
2) Patient with para-functional habits
3) Patient with low osseointegrated implant
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1)Type of colony – sealing gel group
2)Type of colony –unsealed group
3) No. of colony seen - sealing gel group
4) No. of colony seen -unsealed group
 
After 15 -20 days  
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "30"
Final Enrollment numbers achieved (India)="30" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   05/09/2023 
Date of Study Completion (India) 07/03/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

This study is randomized clinical Control trial consisting of 2 groups with an aim , the effect of sealing gel on bacterial microleakage at implant abutment junction

 

Objective  

1)Type of Colony seen in samples with and without  sealing gel

2) No. of Colony seen in samples with and without  sealing gel

Randomization technique

Each eligible patient who have opted to undergo implant treatment will be subjected to random lottery method.

Each patient will be asked to pick up a lottery chit out of the 4 chits. The chits include:

1)RS (Right side with sealing gel )

2)LS (Left side with sealing gel)

3)RWS (Right side without sealing gel)

4)LWS(Left side without sealing gel)

 

All patient satisfying the Inclusion criteria and Exclusion criteria of this randomized clinical control trial will be include in this study A total sample size of 30 will be selected-Study groups 

Sample size: 15 for each group (30 Total samples) with 2 site of implants in each ,test and control site will be allocated randomly using the above mentioned lottery system

VARIABLES 

1)Type of colony â€“ sealing gel

2)Type of colony â€“without sealing gel

3) No. of colony seen - sealing gel

4) No. of colony seen - without sealing gel

 

1.     Patient selection:

Patient requiring implant supported prosthesis.

2.     Second stage surgery and Sterile field assessment

Implant will be isolated with sterile cotton wool rolls and suction. At the time of Second stage surgery before injecting gap seal in internal compartment of implant and placing abutment, sterilization of compartment with chlorhexidine solution (30sec-2min) both group, prior injecting sealing gel in group A and group B(without sealing gel), to assess sterile field, introduce 10 µl of sterile saline into the internal compartment of the implant with Insulin syringe (as determined prior to the commencement of the study, the internal volume of the implants was able to accommodate saline volume in excess of 10 µl) and immediately drawn back up from internal compartment of the implant and microbial assessment will be done by culturing saline sample. A sterile syringe will be used and discarded after each sample.

3.     Microleakage assessment

After removal of  abutment (15-20 days) immediately Insulin syringe will be used to introduce of sterile saline into the internal compartment of the implant, the internal volume of the implants will able to accommodate saline volume. A sterile syringe will be used and discarded after each sample. The saline will immediately drawn back up and transferred into a sterile Brain Heart Infusion Broth (BHI) and microbial assessment will be done by CFUs and measured in both sealing gel and conventional method. Any calculus present on the implant neck will be removed

 

 

STATISTICAL ANALYSIS

It will be done by applying Mann whitney U test ,Chi-square test

 

Protocol No change in the study procedure shall be affected without the mutual agreement of investigator, dentist and ethical committee approval. No hazardous materials will be used. The identity of patient generated in the study will be bounded in strict confidence. The remaining data will be available only to the investigator involved in the study and to the regulatory authorities. Break in the confidentiality is possible only after detail review by the investigator and with the permission of the ethical committee. Information will be disclosed to the concerned person/authority under special circumstances like severe unreported untoward reactions


 
Close